Evidence map›Paper›PMID 41471918›Full record

ReviewMicroorganisms2025

Current Scientific Advances in Vaccines Against UTIs: Challenges and Prospects.

Baoying Wang, Yuhui Wang, Haodi Liu, Mingyang Yu, Shuaishuai Wang, Lele Liu, Hailong Wang, Daizhou Zhang, Haining Tan

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. UropathogenicAntibiotics (Basel, Switzerland) · 2026
    Review
  2. Therapeutic strategies for multi-resistantJAC-antimicrobial resistance · 2026
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Baoying WangNational Glycoengineering Research Center, Shandong University, Qingdao 266237, China.
Yuhui WangNational Glycoengineering Research Center, Shandong University, Qingdao 266237, China.
Haodi LiuNational Glycoengineering Research Center, Shandong University, Qingdao 266237, China.
Mingyang YuSchool of Life Sciences, Shandong University, Qingdao 266237, China.
Shuaishuai WangNational Glycoengineering Research Center, Shandong University, Qingdao 266237, China.ORCID 0000-0002-8346-9159
Lele LiuSchool of Life Sciences, Shandong University, Qingdao 266237, China.ORCID 0000-0002-5980-0761
Hailong WangState Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.ORCID 0000-0001-9874-5892
Daizhou ZhangShandong Academy of Pharmaceutical Sciences, Jinan 250101, China.
Haining TanNational Glycoengineering Research Center, Shandong University, Qingdao 266237, China.

Funding

China Postdoctoral Science Foundation 2025M772772Intramural Join Program Fund of State Key Laboratory of Microbial Technology NOSKLMTIJP-2025-03National Key Research and Development Program 2023YFF1103603National Natural Science Foundation of China 82473831 and 32501296Qingdao Natural Science Foundation 24-4-4-zrjj-32-jchShandong Provincial Natural Science Foundation ZR2024QC285
6 · The paper itself

Abstract

Urinary Tract Infection (UTI), the second most common infectious disease globally, poses a particularly significant threat to adult female populations. Epidemiological data show that Uropathogenic

Indexed as

antibiotic resistancebiosynthesispolysaccharide conjugate vaccinesurinary tract infectionuropathogenic Escherichia coli

Identifiers

PMID41471918
PMCPMC12735469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.